Enlargement of price limit benefited pharmaceutical stocks, increasing 20% in a favorable condition
Since the 15th of this month, enlargement of price limit from 15% to 30% has benefited stock price of pharmaceutical companies.
Although an opinion was raised that the spread of MERS might stop the uptrend of pharmaceutical stocks, the new drug development expectation has continued the trend.
O...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
